SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the 2nd joint survey 2024
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-026-07790-w ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Oliver Lindner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Radiology, Nuclear Medicine, and Molecular Imaging, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany. oli…. Hauptthemen laut MEDLINE: Myocardial Perfusion Imaging, Tomography, Emission-Computed, Single-Photon, Positron-Emission Tomography. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ruhr-Universität Bochum.
Abstract (Originalsprache)
PURPOSE: We herein present the results of the second survey on SPECT and PET myocardial perfusion imaging (MPI) in Austria, Germany, and Switzerland in 2024. METHODS: A questionnaire was sent to facilities practicing nuclear medicine. RESULTS: Data from 12 Austrian (10,689 SPECT), 198 German (128,707 SPECT), and 16 Swiss departments (11,593 MPI (2,911 SPECT; 8,682 PET)) were analysed. In Austria and Germany, the PET MPI numbers were negligible and not considered. In Austria 50%, in Germany 69%, and in Switzerland 69% of the facilities reported stable or increasing numbers of examinations compared to the 2021 survey. Ambulatory care cardiologists represented the major referral group (46-71%). Most stress tests were performed pharmacologically (57-96%). In SPECT imaging, the one-day protocol was predominant in Switzerland (77%), while the two-day protocol was used in Austria (41%) and Germany (49%). The primary camera systems used were hybrid SPECT-CT systems in Austria (75%) and Switzerland (100%), and SPECT cameras (without CT) in Germany (56%). Attenuation correction was regularly performed in Switzerland (100%), followed by Austria (74%), and Germany (35%). Both gated SPECT and perfusion scoring were frequently applied (gated SPECT 82-99%; perfusion scoring 82-88%). CONCLUSIONS: This second joint survey for 2024 confirms positive trends in MPI imaging in all three countries, albeit with differences. The results document a high level of guideline conformity. The situation in Switzerland is exceptional due to the widespread use of PET-MPI. Switzerland also leads in terms of camera equipment and attenuation correction followed by Austria and Germany.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Radiology, Nuclear Medicine, and Molecular Imaging, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany. oliver.lindner@ruhr-uni-bochum.de.
- Department of Radiology, Division of Nuclear Medicine, Medical University of Graz, Graz, Austria.
- Institute for Radiology, Nuclear Medicine, and Molecular Imaging, Heart and Diabetes Center NRW, Ruhr University Bochum, Bad Oeynhausen, Germany.
- Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.
ORCID-Profile: Oliver Lindner, J Bucerius, T Derlin, W Burchert, R R Buechel
Förderung
- Ruhr-Universität Bochum
Zitieren
APA
Lindner, O., Bucerius, J., Derlin, T., Burchert, W., & Buechel, R. R. (2026). SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the 2nd joint survey 2024. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-07790-w
Vancouver
Lindner O, Bucerius J, Derlin T, Burchert W, Buechel RR. SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the 2nd joint survey 2024. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-07790-w
BibTeX
@article{Lindner2026,
author = {Lindner, Oliver and Bucerius, J and Derlin, T and Burchert, W and Buechel, R R},
title = {SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the 2nd joint survey 2024},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-026-07790-w}
}
EUVIMED